Invention Grant
- Patent Title: Process and intermediates
-
Application No.: US16452452Application Date: 2019-06-25
-
Publication No.: US11434192B2Publication Date: 2022-09-06
- Inventor: Florian Karl Kleinbeck-Riniker , Benjamin Martin , Gerhard Penn , Francesco Venturoni , Thierry Schlama , Thomas Ruch , Thomas Allmendinger , Bernhard Wietfeld , Paolo Filipponi
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Timothy P. O'Dea
- Priority: EP15199378 20151210,EP16198655 20161114
- Main IPC: C07C59/84
- IPC: C07C59/84 ; C07C67/035 ; C07C213/08 ; C07C69/738 ; C07C313/06 ; C07C229/34 ; C07D265/02 ; C07D207/36 ; C07C251/40 ; C07C251/66 ; C07C51/373
Abstract:
The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
Public/Granted literature
- US20190308927A1 PROCESS AND INTERMEDIATES Public/Granted day:2019-10-10
Information query
